Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 EUR | +0.72% | +0.36% | +19.23% |
Apr. 22 | Cellularline buys 7,000 of its own ordinary shares | AN |
Apr. 15 | Cellularline updates on its buyback program | AN |
Strengths
- The stock, which is currently worth 2024 to 0.53 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- The company has a low valuation given the cash flows generated by its activity.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The company sustains low margins.
Ratings chart - Surperformance
Sector: Computer & Electronics Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.23% | 62.39M | - | ||
-23.95% | 1.17B | B- | ||
-14.36% | 1.16B | - | - | |
+10.21% | 747M | D | ||
-4.23% | 397M | - | ||
-1.40% | 308M | - | - | |
+0.77% | 209M | - | ||
0.00% | 205M | - | - | |
+14.66% | 90.03M | - | - | |
-10.33% | 60.11M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CELL Stock
- Ratings Cellularline S.p.A.